Inflammation-related terms were also downregulated in the Fc(mML1)B3 group, specifically neutrophil-related genes known to contribute to the development of NASH, such as myeloperoxidase (MPO) and S100A8/A949 (Figures 6M and 6O), suggesting the improvement of liver metabolism and suppression of inflammation in the Fc(mML1)B3 group. The gene discussed is S100A8; the disease is metabolic dysfunction-associated steatohepatitis.